|
|
|
|
| LEADER |
02745nam a22005175i 4500 |
| 001 |
978-0-306-47822-2 |
| 003 |
DE-He213 |
| 005 |
20151204143900.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2002 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780306478222
|9 978-0-306-47822-2
|
| 024 |
7 |
|
|a 10.1007/b101928
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC254-282
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.994
|2 23
|
| 245 |
1 |
0 |
|a Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer
|h [electronic resource] /
|c edited by Stanley P. L. Leong.
|
| 264 |
|
1 |
|a Boston, MA :
|b Springer US,
|c 2002.
|
| 300 |
|
|
|a VIII, 120 p. 43 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Cancer Treatment and Research,
|x 0927-3042 ;
|v 111
|
| 505 |
0 |
|
|a Rationale and Development of Sentinel Lymph Node Dissection -- Lymphoscintigraphy in the Detection of Sentinel Lymph Nodes -- Selective Sentinel Lymph Node Mapping and Dissection for Malignant Melanoma -- Selective Sentinel Lymph Node Mapping and Dissection for Breast Cancer -- Pathologic Examination of the Sentinel Lymph Node -- Selective Lymph Node Mapping in Colorectal Cancer – A Propsective Study for Impact on Staging, Limitations and Pitfalls.
|
| 520 |
|
|
|a Atlas of Selective Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer emphasizes a multidisciplinary approach combining the experiences of a nuclear medicine physician, surgeon, and pathologist. This is an important reference also for researchers and clinicians who want to become familiar with sentinel lymph node mapping. The underlying thesis in solid tumor biology is that metastasis in general starts in an orderly progression with lymphatic spread first to the sentinel lymph node (SLN) in the nearest lymph node basin. Therefore, the logical approach is to harvest that specific SLN for thorough analysis.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Nuclear medicine.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
|
0 |
|a Surgical oncology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Surgical Oncology.
|
| 650 |
2 |
4 |
|a Nuclear Medicine.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 700 |
1 |
|
|a Leong, Stanley P. L.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781402070136
|
| 830 |
|
0 |
|a Cancer Treatment and Research,
|x 0927-3042 ;
|v 111
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/b101928
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 912 |
|
|
|a ZDB-2-BAE
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
